{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:47:49Z","timestamp":1764841669556},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.cytogfr.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T01:35:49Z","timestamp":1311471349000},"page":"149-156","source":"Crossref","is-referenced-by-count":13,"title":["Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"22","author":[{"given":"Claudia","family":"Cocco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Airoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2011.05.003_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, immune responses and the aetiology of childhood leukaemia","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0010","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2401939","article-title":"Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983\u20131995","volume":"14","author":"Gaynon","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2141.2003.04499.x","article-title":"Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence","volume":"122","author":"Robison","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/asheducation-2003.1.102","article-title":"Pediatric acute lymphoblastic leukemia","author":"Carroll","year":"2003","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0025","first-page":"233","article-title":"Pre-natal origins of childhood leukemia","volume":"7","author":"Greaves","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.1992.10.4.606","article-title":"Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study","volume":"10","author":"Trueworthy","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.genet.32.1.495","article-title":"The critical role of chromosome translocations in human leukemias","volume":"32","author":"Rowley","year":"1998","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/gcc.2870090307","article-title":"t(12;21): a new recurrent translocation in acute lymphoblastic leukemia","volume":"9","author":"Romana","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0045","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1038\/sj.onc.1206194","article-title":"BCR\/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations","volume":"21","author":"Pane","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00062752-200207000-00004","article-title":"The role of MLL in hematopoiesis and leukemia","volume":"9","author":"Ernst","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1200\/JCO.1997.15.3.1150","article-title":"TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance","volume":"15","author":"Rubnitz","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","volume":"90","author":"Borkhardt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0070","first-page":"1094","article-title":"TEL\/AML1 gene fusion is related to in vitro drug sensitivity for l-asparaginase in childhood acute lymphoblastic leukemia","volume":"96","author":"Ramakers-van Woerden","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0075","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"Dordelmann","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0080","first-page":"2730","article-title":"Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome","volume":"92","author":"Schrappe","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0085","doi-asserted-by":"crossref","unstructured":"Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2010; 24:1\u201318.","DOI":"10.1016\/j.hoc.2009.11.014"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0095","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(05)66998-X","article-title":"Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study","volume":"366","author":"Balduzzi","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2006.06.8312","article-title":"Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial","volume":"25","author":"Ribera","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcl.2007.11.002","article-title":"Biology and treatment of acute lymphoblastic leukemia","volume":"55","author":"Pieters","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0952-7915(99)80027-2","article-title":"The role of cytokine receptor signaling in lymphocyte development","volume":"11","author":"Baird","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0120","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.V96.6.2022","article-title":"Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis","volume":"96","author":"Fortunel","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/07853899909115980","article-title":"Abnormalities of cytokine receptor signalling contributing to diseases of red blood cell production","volume":"31","author":"Goyal","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V96.2.768","article-title":"Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0135","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1182\/blood.V94.11.3717","article-title":"Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia","volume":"94","author":"Aguayo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0140","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cncr.20869","article-title":"Cytokine\/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence","volume":"103","author":"Wu","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.leu.2404152","article-title":"Role of cytokines in the treatment of acute leukemias: a review","volume":"20","author":"Ravandi","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1991.tb08615.x","article-title":"Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study","volume":"77","author":"Foa","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0155","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1182\/blood.V84.7.2158.2158","article-title":"Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia","volume":"84","author":"Meloni","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0160","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.V87.4.1249.bloodjournal8741249","article-title":"Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia","volume":"87","author":"Robinson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V79.2.517.517","article-title":"Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation","volume":"79","author":"Soiffer","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(03)12322-7","article-title":"Recombinant human interleukin 11 and bacterial infection in patients with [correction of] haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial","volume":"361","author":"Ellis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0175","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1200\/JCO.2008.21.3579","article-title":"Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies","volume":"27","author":"Pistoia","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0180","doi-asserted-by":"crossref","first-page":"e6119","DOI":"10.1371\/journal.pone.0006119","article-title":"IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions","volume":"4","author":"Airoldi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0185","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1073\/pnas.0609028104","article-title":"Endogenous IL-12 triggers an antiangiogenic program in melanoma cells","volume":"104","author":"Airoldi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0190","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","article-title":"Interleukin-12 in anti-tumor immunity and immunotherapy","volume":"13","author":"Colombo","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0200","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00262-006-0171-5","article-title":"Immune enhancement and anti-tumour activity of IL-23","volume":"55","author":"Hao","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0205","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/0008-5472.CAN-03-2084","article-title":"Potent antitumor activity of interleukin-27","volume":"64","author":"Hisada","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0210","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/blood-2008-02-139378","article-title":"Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target","volume":"112","author":"Airoldi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0215","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI200420303","article-title":"The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies","volume":"113","author":"Airoldi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0220","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1158\/0008-5472.CAN-05-4418","article-title":"Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells","volume":"66","author":"Airoldi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0225","doi-asserted-by":"crossref","unstructured":"Cocco C, Canale S, Frasson C, Di Carlo E, Ognio E, Ribatti D, et al. Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. Blood 2010;116:3887\u201398.","DOI":"10.1182\/blood-2009-10-248245"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0230","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.leukres.2009.01.020","article-title":"Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group","volume":"33","author":"Lacy","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0235","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1158\/1078-0432.CCR-04-0540","article-title":"Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease","volume":"10","author":"Younes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0240","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1158\/0008-5472.CAN-05-4087","article-title":"Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma","volume":"66","author":"Oniki","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0245","doi-asserted-by":"crossref","unstructured":"Zhu S, Lee DA, Li S. IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol 2010;184:2348\u201354.","DOI":"10.4049\/jimmunol.0902371"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0255","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20072108","article-title":"Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder","volume":"205","author":"O\u2019Connell","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10186","article-title":"High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma","volume":"37","author":"van den Berg","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0265","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0270","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3324\/haematol.2010.026138","article-title":"MicroRNAs characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia","volume":"96","author":"Schotte","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0275","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0280","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0285","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0290","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0300","doi-asserted-by":"crossref","first-page":"19971","DOI":"10.1073\/pnas.0709313104","article-title":"MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia","volume":"104","author":"Mi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0305","doi-asserted-by":"crossref","first-page":"e7826","DOI":"10.1371\/journal.pone.0007826","article-title":"MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0310","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08880010802378338","article-title":"Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia","volume":"26","author":"Ju","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0320","first-page":"157","article-title":"c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture","volume":"22","author":"Simmons","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0325","doi-asserted-by":"crossref","unstructured":"Frenquelli M, Muzio M, Scielzo C, Fazi C, Scarfo L, Rossi C, et al. MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221\/222 cluster and p27. Blood 2010;115:3949\u201359.","DOI":"10.1182\/blood-2009-11-254656"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0330","first-page":"3613","article-title":"Dysregulated expression of miRNAs in polycytemia vera erythroid progenitors","volume":"108","author":"Bruchova","year":"2006","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V86.1.45.bloodjournal86145","article-title":"BCL-6 protein is expressed in germinal-center B cells","volume":"86","author":"Cattoretti","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0350","doi-asserted-by":"crossref","unstructured":"Klusmann JH, Li Z, Bohmer K, Maroz A, Koch ML, Emmrich S, et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 2010;24:478\u201390.","DOI":"10.1101\/gad.1856210"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0345","doi-asserted-by":"crossref","unstructured":"Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A, et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6\/RUNX1 (TEL\/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010;24:89\u201396.","DOI":"10.1038\/leu.2009.208"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0355","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1101\/gad.1767609","article-title":"MicroRNA-125b is a novel negative regulator of p53","volume":"23","author":"Le","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0360","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0365","doi-asserted-by":"crossref","unstructured":"O\u2019Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010;10:111\u201322.","DOI":"10.1038\/nri2708"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0370","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0375","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","article-title":"microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells","volume":"27","author":"Vigorito","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0380","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.molimm.2007.10.035","article-title":"MicroRNA targets in immune genes and the Dicer\/Argonaute and ARE machinery components","volume":"45","author":"Asirvatham","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0385","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2008.11.010","article-title":"miRNA regulation of cytokine genes","volume":"45","author":"Asirvatham","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0390","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.biochi.2007.02.008","article-title":"Post-transcriptional control of the interferon system","volume":"89","author":"Khabar","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0395","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/MCB.26.6.2408-2418.2006","article-title":"Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways","volume":"26","author":"Brook","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0400","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cytogfr.2009.10.004","article-title":"Control of microRNA biogenesis by TGFbeta signaling pathway\u2014a novel role of Smads in the nucleus","volume":"20","author":"Hata","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0405","doi-asserted-by":"crossref","unstructured":"David M. Interferons and microRNAs. J Interferon Cytokine Res 2010;30:825\u20138.","DOI":"10.1089\/jir.2010.0080"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0410","doi-asserted-by":"crossref","unstructured":"Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM. Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK\/STAT pathway. Biochem Biophys Res Commun 2010;402:390\u20135.","DOI":"10.1016\/j.bbrc.2010.10.042"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0415","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O\u2019Connell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0420","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0425","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","article-title":"Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway","volume":"104","author":"Brock","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0430","doi-asserted-by":"crossref","unstructured":"McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR, Murray PJ, et al. IL-10 inhibits miR-155 induction by toll-like receptors. J Biol Chem 2010;285:20492\u20138.","DOI":"10.1074\/jbc.M110.102111"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0435","doi-asserted-by":"crossref","unstructured":"Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010;11:1057\u201362.","DOI":"10.1038\/ni.1945"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0440","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0445","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","article-title":"The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities","volume":"14","author":"Bonci","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2011.05.003_bib0450","unstructured":"Canale S, Cocco C, Frasson C, Seganfreddo E, Di Carlo E, Ognio E, et al. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a pre-clinical model. Leukemia, in press."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610111000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610111000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T15:22:41Z","timestamp":1592752961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610111000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1359610111000256"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2011.05.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}